McKesson Investing Cash Flow decreased by 1224.9% to -$3.56B in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 3996.6%, from -$87.00M to -$3.56B.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$99.00M | $215.00M | -$414.00M | $39.00M | -$354.00M | -$180.00M | -$47.00M | -$149.00M | -$224.00M | -$136.00M | -$563.00M | -$87.00M | -$3.50B | -$269.00M | -$3.56B |
| QoQ Change | — | +317.2% | -292.6% | +109.4% | <-999% | +49.2% | +73.9% | -217.0% | -50.3% | +39.3% | -314.0% | +84.5% | <-999% | +92.3% | <-999% |
| YoY Change | — | — | — | +139.4% | -264.7% | +56.5% | — | -482.1% | +36.7% | +24.4% | <-999% | +41.6% | <-999% | -97.8% | <-999% |